The development of activators typically involves the use of various techniques including high-throughput screening to identify compounds that can modulate the activity of the target protein. Subsequent studies such as biochemical assays, structural biology, and computational modeling would provide insight into the mechanism of action of these compounds. The activators might interact directly with the SSTK-IP, inducing a conformational change that enhances its activity, or they could bind to a regulatory site that modulates its function. Detailed SAR studies would be essential to optimize these compounds for increased potency and specificity, ensuring that they precisely modulate the activity of SSTK-IP without off-target effects. Advanced techniques such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy could be employed to elucidate the structure of SSTK-IP in complex with the activator, providing valuable information for the refinement of compound design.
In the absence of specific information about SSTK-IP, it is challenging to provide a detailed description of activators for this target. However, the general principles of activator development and the techniques used to study them would be applicable across a wide range of proteins and cellular targets in the field of biochemical research.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
As a hormone, it may regulate gene expression in reproductive tissues, potentially affecting TSSK6IP levels. |